Delivery Order SPE2DB24D2205-SPE2DB25FEBHV

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,714,237 units of Methylphenidate ER 36 mg tablets in 100-count bottles, with a ceiling value of $1,580.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 27, 2025. This contract award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $1,012.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the provision of 4567944679 - Methylphenidate ER 36 mg tablets, a neurological medication. The contract has a firm fixed price and an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,122,144 units of Methylphenidate ER 36 mg tablets in 100-count bottles. The firm-fixed-price delivery order, valued at $1,183.58, has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,144.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,013,659 units of Methylphenidate ER 36 mg tablets, a prescription medication. This contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.98 firm fixed-price delivery order is for the supply of 4,567,786,336 tablets of Methylphenidate ER 36 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,771.37, is for the delivery of Methylphenidate ER 36 mg tablets, a prescription medication. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $2,679.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,988,472 units of the medication Methylphenidate ER 36 mg tablets, with a performance period ending on April 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,175.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4567965336 - Methylphenidate ER 54 mg Tablets, 100-count, with an ultimate completion date of April 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,618,148 units of Methylphenidate ER 18 mg tablets. The $1,328.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through March 19, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $1,774.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 36 mg tablets in units of 30, with an ultimate completion date of March 28, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. AmerisourceBergen holds a significant...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBHV
    Delivery Order

This federal contract award, valued at $1,483.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,997,959 units of Methylphenidate ER 36 mg tablets, a neurological medication, with a performance period through April 2025.

The contract is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 with a performance period through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 7/22/25, 9:46 AM